SMART-ALD - A New Lifestyle Intervention to Improve Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

May 20, 2022

Primary Completion Date

November 1, 2023

Study Completion Date

February 1, 2024

Conditions
X-linked Adrenoleukodystrophy
Interventions
BEHAVIORAL

SMART-ALD

At the beginning of SMART-ALD, a multi-professional team evaluates participant's current health status and develops an individual treatment plan together with the participant. The SMART-ALD intervention offers medical, psychological, and social counseling, as well as a physical fitness and disease-specific nutritional program carried out via video consultation. Thus, scope and intensity of SMART-ALD intervention is initially tailored to individual needs and continuously adapted to changes during intervention.

BEHAVIORAL

Waiting list

At the beginning of the study, patients of the waiting list (WL) control condition receive one medical consultation via video consultation, including recommendations to contact their local treating physician if necessary. Individuals are instructed not to seek any other medical or psychological treatment for X-ALD symptoms without informing the study staff. All WL patients are guaranteed 6 months of SMART-ALD intervention after a waiting period of 6 months.

Trial Locations (2)

04103

Leipzig University Medical Center, Leukodystrophy Outpatient Clinic, Department of Neurology, Leipzig, Germany, Leipzig

04275

Leukodystrophy Outpatient Clinic, Leipzig

All Listed Sponsors
collaborator

European Leukodystrophy Association

OTHER

lead

Leipzig University Medical Center

OTHER